Sharon E. Frey

7.5k total citations · 1 hit paper
127 papers, 4.8k citations indexed

About

Sharon E. Frey is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Sharon E. Frey has authored 127 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 49 papers in Virology and 44 papers in Immunology. Recurrent topics in Sharon E. Frey's work include Influenza Virus Research Studies (30 papers), Poxvirus research and outbreaks (30 papers) and Immunotherapy and Immune Responses (28 papers). Sharon E. Frey is often cited by papers focused on Influenza Virus Research Studies (30 papers), Poxvirus research and outbreaks (30 papers) and Immunotherapy and Immune Responses (28 papers). Sharon E. Frey collaborates with scholars based in United States, Switzerland and Canada. Sharon E. Frey's co-authors include Robert B. Belshe, Frances K. Newman, Mark Wolff, Robert L. Atmar, Heather Hill, Jeffrey S. Kennedy, Francis A. Ennis, Michael Houghton, Carol O. Tacket and John J. Treanor and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Sharon E. Frey

124 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 110 citations Sharon E. Frey, Rebecca L. Morgan et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon E. Frey United States	42	2.4k	1.8k	1.5k	1.5k	1.3k	127	4.8k
M L Clements United States	44	2.7k 1.1×	1.3k 0.7×	1.0k 0.7×	2.7k 1.9×	2.0k 1.5×	93	7.8k
Shan Lu United States	40	1.6k 0.7×	1.9k 1.1×	1.6k 1.1×	1.7k 1.2×	2.4k 1.8×	168	5.3k
Mark Wolff United States	38	3.6k 1.5×	640 0.4×	789 0.5×	1.6k 1.1×	1.3k 0.9×	63	5.3k
Srinivas S. Rao United States	27	2.3k 1.0×	2.9k 1.6×	1.3k 0.9×	2.3k 1.6×	2.7k 2.0×	53	6.5k
Robert T. Bailer United States	42	1.6k 0.7×	2.7k 1.5×	1.4k 0.9×	2.5k 1.7×	2.5k 1.9×	79	5.9k
Anders Fomsgaard Denmark	38	1.4k 0.6×	730 0.4×	1.3k 0.8×	1.5k 1.0×	1.4k 1.1×	190	4.8k
Sanjay Gurunathan United States	28	1.8k 0.8×	785 0.4×	1.1k 0.7×	1.0k 0.7×	1.9k 1.4×	46	4.4k
Jean‐Louis Excler United States	31	858 0.4×	1.4k 0.8×	721 0.5×	1.2k 0.8×	932 0.7×	116	3.0k
Punnee Pitisuttithum Thailand	30	2.0k 0.8×	1.2k 0.7×	546 0.4×	1.6k 1.1×	904 0.7×	145	4.1k
Eric Sandström Sweden	35	1.2k 0.5×	1.7k 0.9×	612 0.4×	1.6k 1.1×	917 0.7×	169	3.9k

Countries citing papers authored by Sharon E. Frey

Since Specialization

Citations

This map shows the geographic impact of Sharon E. Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Frey more than expected).

Fields of papers citing papers by Sharon E. Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Frey. The network helps show where Sharon E. Frey may publish in the future.

Co-authorship network of co-authors of Sharon E. Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Frey. A scholar is included among the top collaborators of Sharon E. Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Frey. Sharon E. Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frey, Sharon E., Rebecca C. Brady, Lisa A. Jackson, et al.. (2025). Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®. Vaccine. 47. 126702–126702. 1 indexed citations

Belshe, Robert B., David I. Bernstein, Kathryn M. Edwards, et al.. (2025). Vaccine and Treatment Evaluation Units: A Historical Perspective. Clinical Infectious Diseases. 81(Supplement_2). S59–S77.

Healy, Catherine, C. Buddy Creech, Sharon E. Frey, et al.. (2025). 579. Safety and Immunogenicity of Mpox Vaccination in Adolescents. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Winokur, Patricia, Theresa Hegmann, Wendy A. Keitel, et al.. (2023). Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults. Clinical Infectious Diseases. 9 indexed citations

Ortiz, Justin R., David I. Bernstein, Daniel F. Hoft, et al.. (2023). A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. The Journal of Infectious Diseases. 228(3). 287–298. 6 indexed citations

Venkatapathy, Raghuraman, Heath Mash, Lesley V. D’Anglada, et al.. (2022). Determination of Cyanotoxins and Prymnesins in Water, Fish Tissue, and Other Matrices: A Review. Toxins. 14(3). 213–213. 23 indexed citations

Scherer, Erin M., Martín Bäcker, Lara Danziger‐Isakov, et al.. (2022). The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action. Clinical Infectious Diseases. 76(4). 753–759. 4 indexed citations

Rao, Agam K., Deborah J. Briggs, Susan M. Moore, et al.. (2022). Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morbidity and Mortality Weekly Report. 71(18). 619–627. 34 indexed citations

Muñoz, Flor M., Shital M. Patel, Lisa A. Jackson, et al.. (2020). Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants. Vaccine. 38(33). 5355–5363. 17 indexed citations

10.

Widdice, Lea E., Rebecca Hoagland, S. Todd Callahan, et al.. (2018). Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. Vaccine. 36(11). 1491–1499. 8 indexed citations

11.

Widdice, Lea E., Elizabeth R. Unger, Gitika Panicker, et al.. (2018). Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals. Vaccine. 36(6). 881–889. 7 indexed citations

12.

Abate, Getahun, et al.. (2017). Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. Therapeutic Advances in Infectious Disease. 5(1). 11–18. 46 indexed citations

13.

Rasmussen, Sonja A., Sonia Hernández–Dı́az, Omar Abdul‐Rahman, et al.. (2014). Assessment of Congenital Anomalies in Infants Born to Pregnant Women Enrolled in Clinical Trials. Clinical Infectious Diseases. 59(suppl_7). S428–S436. 13 indexed citations

14.

Frey, Sharon E., Patricia Winokur, Robert A. Salata, et al.. (2013). Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario. Vaccine. 31(29). 3025–3033. 50 indexed citations

15.

Hughes, Christine M., Frances K. Newman, Whitni Davidson, et al.. (2012). Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox Vaccines. Clinical and Vaccine Immunology. 19(7). 1116–1118. 12 indexed citations

16.

Monath, Thomas P. & Sharon E. Frey. (2008). Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis. Vaccine. 27(10). 1645–1650. 9 indexed citations

17.

Frey, Sharon E., Frances K. Newman, Jeffrey S. Kennedy, et al.. (2007). Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge. Vaccine. 25(51). 8562–8573. 92 indexed citations

18.

Russell, Nina D., Barney S. Graham, Michael C. Keefer, et al.. (2006). Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 203–212. 69 indexed citations

19.

Belshe, Robert B., Frances K. Newman, Sharon E. Frey, et al.. (2004). Dose‐Dependent Neutralizing‐Antibody Responses to Vaccinia. The Journal of Infectious Diseases. 189(3). 493–497. 30 indexed citations

20.

Gilbert, Peter B., Ya Lin Chiu, Mary Allen, et al.. (2003). Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials. Vaccine. 21(21-22). 2933–2947. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact